Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach
暂无分享,去创建一个
[1] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[2] L. Weinberger,et al. Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques , 1999, The Journal of experimental medicine.
[3] P. Schnyder,et al. Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy , 1998, Nature Medicine.
[4] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[5] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[6] A. Perelson,et al. Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine , 1998, AIDS.
[7] M. Nowak,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy , 1999, Journal of Virology.
[8] H. Resit Akçakaya,et al. Consequences of Ratio‐Dependent Predation for Steady‐State Properties of Ecosystems , 1992 .
[9] Peter A. Abrams,et al. The Fallacies of "Ratio‐Dependent" Predation , 1994 .
[10] P. Easterbrook,et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[12] C. Boucher,et al. Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model , 1997, Journal of virology.
[13] A S Perelson,et al. Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.
[14] C. Boucher,et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. , 1998, The Journal of infectious diseases.
[15] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] P D Griffiths,et al. Population dynamics of HIV within an individual after treatment with zidovudine , 1991, AIDS.
[17] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[18] R J D B,et al. Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .
[19] R. Arditi,et al. Coupling in predator-prey dynamics: Ratio-Dependence , 1989 .
[20] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[21] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.
[22] Peter J. Morin,et al. Productivity controls food-chain properties in microbial communities , 1998, Nature.
[23] Steven G. Deeks,et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans , 1999, Nature Medicine.
[24] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[25] J. S. Sullivan,et al. Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.
[26] M. Zupancic,et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.
[27] C. Rinaldo,et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.
[28] Martin A. Nowak,et al. Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA , 1999, The Journal of experimental medicine.
[29] Robin A. Weiss,et al. How does HIV cause AIDS , 1993 .
[30] Andrew H. Liu,et al. HIV INFECTION IS ACTIVE AND PROGRESSIVE IN LYMPHOID TISSUE DURING THE CLINICALLY LATENT STAGE OF DISEASE , 1995, Pediatrics.
[31] M. Zupancic,et al. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[33] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[34] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[35] L M Wahl,et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[37] K. Überla,et al. Suppression of Acute Viremia by Short-Term Postexposure Prophylaxis of Simian/Human Immunodeficiency Virus SHIV-RT-Infected Monkeys with a Novel Reverse Transcriptase Inhibitor (GW420867) Allows for Development of Potent Antiviral Immune Responses Resulting in Efficient Containment of Infection , 2000, Journal of Virology.
[38] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[39] A S Perelson,et al. Rate of HIV‐1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen , 1998, AIDS.
[40] C. Benson,et al. Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .
[41] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[42] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[43] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[44] M A Nowak,et al. Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.
[45] M. Rosenzweig. Paradox of Enrichment: Destabilization of Exploitation Ecosystems in Ecological Time , 1971, Science.
[46] J. Lundgren,et al. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.